Hairong Xu, MD

Associate Chief Physician/Associate professor
Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Peking University, China (People's Republic)

Beijing Ji Shui Tan Hospital, Associate Chief Physician, Associate professor, Assistant Director, Master Supervisor;
Director of Chinese Society of Clinical Oncology (CSCO);
Expert Committee on sarcoma of Chinese Society of Clinical Oncology (CSCO), Member and Secretary;
Committee on Scarcoma of of China Anti-Cancer Association (CACA), member of standing Committee;
Committee on Translational Medicine of Chinese Medicine Education Association (CMEA), member of standing Committee.

Poster(s):

• (P 361) PEXIDARTINIB FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMORS: CLINICAL EXPERIENCE FROM FIVE CHINESE PATIENTS

• (P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY